AR and prostate carcinoma: PROTAC 10 (Table 3) was effective in inducing AR degradation at concentrations lower than 1 nM in LNCaP and VCaP prostate cancer cell lines with a 24 h treatment time and was capable of achieving complete AR degradation in these cell lines.